Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 450

1.

Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.

Westfall DE, Folpe AL, Paner GP, Oliva E, Goldstein L, Alsabeh R, Gown AM, Amin MB.

Am J Surg Pathol. 2009 Jan;33(1):99-105. doi: 10.1097/PAS.0b013e318180c899.

PMID:
18941404
2.
3.

Sarcomatoid carcinoma of the penis: a clinicopathologic study of 15 cases.

Velazquez EF, Melamed J, Barreto JE, Aguero F, Cubilla AL.

Am J Surg Pathol. 2005 Sep;29(9):1152-8.

PMID:
16096403
4.
5.

Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder.

Sukov WR, Cheville JC, Carlson AW, Shearer BM, Piatigorsky EJ, Grogg KL, Sebo TJ, Sinnwell JP, Ketterling RP.

Mod Pathol. 2007 May;20(5):592-603. Epub 2007 Mar 30.

6.
7.

An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.

Dunne B, Lee AH, Pinder SE, Bell JA, Ellis IO.

Hum Pathol. 2003 Oct;34(10):1009-15.

PMID:
14608534
8.
9.
10.

Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.

Montgomery EA, Shuster DD, Burkart AL, Esteban JM, Sgrignoli A, Elwood L, Vaughn DJ, Griffin CA, Epstein JI.

Am J Surg Pathol. 2006 Dec;30(12):1502-12.

PMID:
17122505
11.

Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma.

Paner GP, Shen SS, Lapetino S, Venkataraman G, Barkan GA, Quek ML, Ro JY, Amin MB.

Am J Surg Pathol. 2009 Jan;33(1):91-8. doi: 10.1097/PAS.0b013e3181804727.

PMID:
18936687
12.

Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference.

Amin MB, Trpkov K, Lopez-Beltran A, Grignon D; Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group.

Am J Surg Pathol. 2014 Aug;38(8):e20-34. doi: 10.1097/PAS.0000000000000240.

PMID:
25029121
13.

ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder.

Tsuzuki T, Magi-Galluzzi C, Epstein JI.

Am J Surg Pathol. 2004 Dec;28(12):1609-14.

PMID:
15577680
14.
15.

Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.

Genega EM, Hutchinson B, Reuter VE, Gaudin PB.

Mod Pathol. 2000 Nov;13(11):1186-91.

16.

Immunohistochemical distinction of cutaneous spindle cell carcinoma.

Morgan MB, Purohit C, Anglin TR.

Am J Dermatopathol. 2008 Jun;30(3):228-32. doi: 10.1097/DAD.0b013e31816de820.

PMID:
18496422
17.

Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms.

Attanoos RL, Dojcinov SD, Webb R, Gibbs AR.

Histopathology. 2000 Sep;37(3):224-31.

PMID:
10971698
18.
19.

Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.

Cox RM, Schneider AG, Sangoi AR, Clingan WJ, Gokden N, McKenney JK.

Am J Surg Pathol. 2009 Aug;33(8):1213-9. doi: 10.1097/PAS.0b013e3181a8ffbe.

PMID:
19542871
20.

Supplemental Content

Support Center